Precision Therapeutics
Precision Therapeutics is a life-science company committed to improving outcomes of cancer patients. As leaders in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual’s cancer. Precision’s state of the art bioinformatics combined with the analysis of the live molecular, proteomic, and genomic activity of each patient’s cancer offers an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy. Precision’s first commercial test, ChemoFx®, is a proprietary drug response marker that measures an individual’s malignant tumor response to a range of chemotherapy alternatives under consideration by a physician with the goal of optimizing patient outcomes.
Precision Therapeutics is a life-science company committed to improving outcomes of cancer patients. As leaders in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual’s cancer. Precision’s state of the art bioinformatics combined with the analysis of the live molecular, proteomic, and genomic activity of each patient’s cancer offers an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy. Precision’s first commercial test, ChemoFx®, is a proprietary drug response marker that measures an individual’s malignant tumor response to a range of chemotherapy alternatives under consideration by a physician with the goal of optimizing patient outcomes.
Company Location
Related Team Members
